Fabrizi, F.; Tripodi, F.; Cerutti, R.; Nardelli, L.; Alfieri, C.M.; Donato, M.F.; Castellano, G.
Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease. Viruses 2022, 14, 2570.
https://doi.org/10.3390/v14112570
AMA Style
Fabrizi F, Tripodi F, Cerutti R, Nardelli L, Alfieri CM, Donato MF, Castellano G.
Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease. Viruses. 2022; 14(11):2570.
https://doi.org/10.3390/v14112570
Chicago/Turabian Style
Fabrizi, Fabrizio, Federica Tripodi, Roberta Cerutti, Luca Nardelli, Carlo M. Alfieri, Maria F. Donato, and Giuseppe Castellano.
2022. "Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease" Viruses 14, no. 11: 2570.
https://doi.org/10.3390/v14112570
APA Style
Fabrizi, F., Tripodi, F., Cerutti, R., Nardelli, L., Alfieri, C. M., Donato, M. F., & Castellano, G.
(2022). Recent Information on Pan-Genotypic Direct-Acting Antiviral Agents for HCV in Chronic Kidney Disease. Viruses, 14(11), 2570.
https://doi.org/10.3390/v14112570